Educate Why Aduhelm Isn't a Miracle for Alzheimer's
You'll hear controversy about Aduhelm (aducanumab), the first new med for Alzheimer's disease in almost 20 years.
It's a monoclonal antibody given as an IV infusion every 4 weeks.
Patients with Alzheimer's and their families are often looking for a glimmer of hope. But Aduhelm doesn't seem to be it.